Christ Hospital launches CRISPR gene-editing trial for patients with high cholesterol

What is the mechanism of the VERVE-201 gene-editing treatment?

Why is lipoprotein A a significant cardiovascular risk factor?…

Story continues

TRENDING NOW

LATEST LOCAL NEWS